MLLT10 and acute myeloid leukemia: For example, Yamauchi et al. performed a genome-wide CRISPR/Cas9 screen in murine AML models with the oncogenic fusions CALM/AF10 and MLL/AF9 and identified DCPS as a promising target for AML [41,42].